Healthcare >> CEO Interviews >> December 2, 1999
LOUIS LANGE, MD. Ph.D was a founder of CV Therapeutics and has served as
the Chairman of the Board and Chief Executive Officer since August 1992.
From July 1980 to August 1992, Dr. Lange served on the faculty of
Washington University School of Medicine, including as Chief of
Cardiology at Jewish Hospital in St. Louis, Missouri from May 1985 to
August 1992, and as a full Professor of Medicine from July 1990 until
August 1992. Dr. Lange is internationally recognized as an expert in
the field of molecular mechanisms of cardiovascular disease. He holds a
M.D. from Harvard Medical School and a Ph.D. in Biochemistry from
Harvard University. He was recently on the Board of Directors of
Cardiac Pathways Corporation and is currently on the Board of Directors
of the University of Rochester and the Biotechnology Industry
Organization Emerging Companies Governing Section. Profile
Dr. Lange: CVT was founded in 1992. We went public in 1996. The focus
of our company is to identify, develop and, ultimately, sell
